Research suggests cannabinoids could benefit MS through two mechanisms: shifting immune responses from harmful Th1 to protective Th2 patterns, and providing neuroprotective effects through neurotransmitter modulation.
Read this if you have MS or want to understand the immune system mechanisms behind cannabinoid treatments for autoimmune diseases.
Cannabinoids shift immune balance from harmful Th1 to protective Th2 responses in MS
What the researchers found
This review compiled evidence on cannabinoids and endocannabinoids in the context of MS as a central nervous system autoimmune disease. Evidence suggests cannabinoids can benefit MS through multiple mechanisms.
On the immune side, cannabinoids down-regulate the production of pathogenic T helper 1 (Th1) cytokines while enhancing protective T helper 2 (Th2) cytokines. This Th1-to-Th2 shift has been associated with therapeutic benefit in MS.
On the neurological side, cannabinoids exert neuromodulatory effects on neurotransmitters and hormones involved in the neurodegenerative phase of the disease.
Animal studies using experimental allergic encephalomyelitis (EAE), an established model of MS, suggest that increasing circulating levels of endocannabinoids could have therapeutic effects. The review proposed that agonists of endocannabinoids with low psychoactive effects could open new treatment strategies for MS.
Why it matters
MS is an autoimmune disease where the immune system attacks the nervous system. The finding that cannabinoids can shift immune responses from harmful to protective patterns while also providing neuroprotection suggests a dual therapeutic mechanism that addresses both the cause and consequences of MS.
The numbers in context
Cannabinoids down-regulate Th1 cytokines and up-regulate Th2 cytokines. EAE animal model studies show increased endocannabinoid levels have therapeutic effects. Endocannabinoids with low psychoactive effects proposed as treatment candidates.
How the study worked
Narrative review examining evidence from immune cell studies, animal models of MS (experimental allergic encephalomyelitis), and clinical observations on how cannabinoids and endocannabinoids interact with the immune system and nervous system in the context of MS.
What this study cannot tell us
Most evidence comes from cell studies and animal models (EAE), which do not perfectly replicate human MS. The review proposes therapeutic strategies rather than demonstrating clinical efficacy. The psychoactive effects of many cannabinoids remain a barrier to clinical development.
How to read the evidence
Narrative review drawing on cell studies and animal models. Provides a coherent mechanistic rationale but limited direct clinical evidence in humans.
When this study was published
Published in 2005. Since then, Sativex has been approved for MS spasticity in multiple countries, and research into endocannabinoid-based MS treatments has continued.
The bigger picture
The concept of using endocannabinoid system modulation to treat autoimmune diseases extends beyond MS. If cannabinoids can shift immune balance and provide neuroprotection simultaneously, this dual mechanism could be relevant for other conditions involving immune-mediated neurological damage.
Questions still open
- Can endocannabinoid agonists with minimal psychoactive effects be developed for MS treatment? Does endocannabinoid modulation work differently in different stages of MS?
Common questions
How might cannabinoids help with MS?
Are there cannabinoid treatments for MS that don't cause a high?
Read the original research
From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.
Current drug targets. CNS and neurological disorders, 4(6), 667-75
Citation
Malfitano, Anna Maria; Matarese, Giuseppe; Bifulco, Maurizio. (2005). From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.. Current drug targets. CNS and neurological disorders, 4(6), 667-75.
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk